Genetic Testing Market Size, Analysis, Research Report, and outlook 2023 – Market Data Forecast

December 07 02:50 2018

Genetic Testing Market Overview

Genetic testing is the analysis of genes, chromosomes, or proteins to predict the risk of diseases, identify carriers (individuals who do not have the disease but have a copy of the disease gene) of disease, diagnose diseases, or determine the likely course of a disease. Genetic testing has enabled the easy diagnosis of diseases, such as sickle cell anemia, haemophilia, and cystic fibrosis, helping several patients in leading a normal life


Request for Sample @


Growing awareness about the potential benefits in genetic testing is one of the primary reasons for the growth of the genetic testing market. In addition, advancements in the genetic testing space, aging population and a subsequent rise in the number of chronic diseases, and rising incidences of cancer cases are the other factors fuelling the growth in the genetic testing market.

However, high costs associated with testing and lack of credible standard procedure has led to serious doubts among individuals concerning the authenticity of genetic reports. These factors are hindering the growth of the global genetic testing market


Genetic Testing Market Forecast Report (2018-2023)

Global Genetic Testing Market is estimated at $ 49.26 million in 2018 and is poised to reach $ 77.58 Million by 2023 growing at a CAGR of 9.51%.


Browse Report Brief and TOC @


Genetic Testing Market Segmentation

The Global genetic testing market is categorized based on application into Cancer Testing, Pharmacogenomics testing, prenatal testing and Predisposition testing. Based on the type of tests, the market is segmented into Carrier Testing, Diagnostic Testing, Prenatal Testing and Neonatal Testing.  Genetic testing is also applied in non-clinical applications such as paternity testing and forensics. Cancer genetic testing is predicted to witness high growth, and would dominate the genetic testing market in the near future. The market for screening the new-borns, diagnosing rare and fatal disorders, and estimating the probability of occurrence of diseases is likely to expand. Particularly, genetic tests to screen the new-borns are expected to expand immensely over the coming years.


Furthermore, on the basis of geography, the global market is analyzed under various regions namely North America, Latin America, Europe, Asia-Pacific, Middle-East & Africa. The US represents the largest market for genetic testing worldwide. Screening for genetic mutations within the CFTR (Cystic Fibrosis Trans-Membrane Conductance Regulator) gene is the most recurrently conducted test in the US.


Major Players: 

The major companies dominating this market for its products and services are

  • Abbott Laboratories,
  • Roche Molecular Diagnostics Inc.,
  • Abbott Molecular Inc.,
  • Auto Genomics Inc.,
  • Celera Group,
  • ELITech Group,
  • Bio-Rad Laboratories,
  • PerkinElmer Inc.,
  • Roche Diagnostics Corp.,
  • Quest Diagnostics Inc.,
  • Tran genomic Inc.,
  • Applied Bios stems Inc.,


Customize Report @


About Us

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.


For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast

Email: [email protected]

Tel: +1-888-702-9626


Media Contact
Company Name: Market Data Forecast
Contact Person: Abhishek Shukla
Email: Send Email
Phone: +1-888-702-9626
Address:2nd Floor, Lakeview Plaza, Kavuri Hills
City: Hyderabad
State: Telangana
Country: India